AstraZeneca lupus drug produces positive results in trial

LONDON, Nov 17 (Reuters) - An experimental lupus drug from AstraZeneca significantly improved the symptoms of lupus in a mid-stage clinical trial, boosting prospects for a medicine the company believes could become a major seller.